These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8549024)

  • 1. The pharmacokinetic properties of topical levocabastine. A review.
    Heykants J; Van Peer A; Van de Velde V; Snoeck E; Meuldermans W; Woestenborghs R
    Clin Pharmacokinet; 1995 Oct; 29(4):221-30. PubMed ID: 8549024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M; Pipkorn U
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine.
    Pesco-Koplowitz L; Hassell A; Lee P; Zhou H; Hall N; Wiesinger B; Mechlinski W; Grover M; Hunt T; Smith R; Travers S
    J Clin Pharmacol; 1999 Jan; 39(1):76-85. PubMed ID: 9987703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM; Vanden Bussche G
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management.
    Howarth PH
    Mediators Inflamm; 1995; 4(7):S26-30. PubMed ID: 18475686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
    Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
    J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.
    Stokes TC; Feinberg G
    Clin Exp Allergy; 1993 Sep; 23(9):791-4. PubMed ID: 10779311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of levocabastine in perennial rhinitis].
    Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
    Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levocabastine--a new antihistaminic for local treatment].
    Larsen BB; Pedersen B; Dahl R
    Ugeskr Laeger; 1993 Jun; 155(26):2070-3. PubMed ID: 8101023
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
    Akiyoshi M; Shigeoka T; Torii S; Maki E; Enomoto S; Takahashi H; Hirano F
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):175-84. PubMed ID: 11915520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C; Wagenmann M; Vossen-Holzenkamp S
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levocabastine in conjunctival provocation studies.
    Janssens M
    Doc Ophthalmol; 1992; 82(4):341-51. PubMed ID: 1363980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early efficacy of topical levocabastine in patients with allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Okamoto S; Nakagawa Y; Uchio E; Yokoi N; Fukushima A; Takamura E
    Allergol Int; 2006 Sep; 55(3):301-3. PubMed ID: 17075271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R; Pedersen B; Larsen B
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
    Palma-Carlos AG; Chieira C; Conde TA; Cordeiro JA
    Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of levocabastine eye drops.
    Janssens M; Blockhuys S
    Doc Ophthalmol; 1993; 84(2):111-8. PubMed ID: 7905376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.